论文信息 - OPTIMUM PHENYTOIN-DOSAGE REGIMENS - 字舞流文

OPTIMUM PHENYTOIN-DOSAGE REGIMENS

T. M. Ludden | D. W. Hawkins | T. Ludden | J. P. Allen | S. F. Hoffman | J. Allen | S. Hoffman

[1] J. J. Anthony. Malignant lymphoma associated with hydantoin drugs. , 1970, Archives of neurology.

[2] A. Steinberg,et al. Loss of suppressor function as a cause of lymphoid malignancy. , 1973, Lancet.

[3] W. Jusko,et al. Diphenylhydantoin elimination kinetics in overdosed children , 1975, Clinical pharmacology and therapeutics.

[4] A. J. Robins,et al. Phenytoin dose adjustment in epileptic patients. , 1974, British journal of clinical pharmacology.

[5] A. Richens,et al. PHENYTOIN DOSAGE NOMOGRAM , 1975, The Lancet.

[6] D. S. Riggs,et al. A COMPARISON OF ESTIMATES OF MICHAELIS-MENTEN KINETIC CONSTANTS FROM VARIOUS LINEAR TRANSFORMATIONS. , 1965, The Journal of biological chemistry.

[7] P. Phillips,et al. SERUM-PHENYTOIN LEVELS , 1975, The Lancet.

[8] A. Richens,et al. SERUM-PHENYTOIN LEVELS IN MANAGEMENT OF EPILEPSY , 1975, The Lancet.

[9] T. Sorrell,et al. Depression of immunological function in patients treated with phenytoin sodium (sodium diphenylhydantoin). , 1971, Lancet.

[10] G. Vawter,et al. Malignant lymphoma after diphenylhydantoin (dilantin) therapy , 1975, Cancer.

[11] J. M. Shaw,et al. Pharmacokinetic study of a patient with diphenylhydantoin toxicity , 1973, Clinical pharmacology and therapeutics.